Skip to content

Stock-Based Comp at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$83M+10.7%
WAT
Waters CorporationWAT
$20M+53.8%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$15.85M-8.8%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$2.4M-35.3%
Lifetime Brands logo
Lifetime BrandsLCUT
$1.04M-1.8%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$1.22M+17.4%

Other financials

Income statement

See full
Revenue$71.4M-7.5%
Gross profit$21.2M-11.6%
Operating income$5.2M-38.6%
Net income$3.4M-30.1%
EPS (diluted)$1.13-30.7%

Balance sheet

See full
Cash & equivalents$10.0M-42.0%
Total debt$25.3M+6.6%
Total equity$74.7M+15.9%
Total assets$178.3M-8.4%

Cash flow

See full
Operating cash flow$5.5M-42.0%
CapEx$928.0K+79.8%
Free cash flow$4.5M-49.0%

Valuation

See full
Market cap$101.96M-34.8%
Enterprise value$117.3M-28.0%
P/E10.6×-3.1×
P/S0.4×-0.3×

Profitability

See full
Gross margin28.5%-0.1pp
Operating margin5.9%-1.5pp
Net margin3.4%-1.3pp
FCF margin5.2%

Returns & leverage

See full
Return on equity13.8%-5.3pp
Debt / equity0.3×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Kewaunee Scientific Corporation’s 10-K, filed June 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kewaunee Scientific Corporation's stock-based comp?
Kewaunee Scientific Corporation (KEQU) reported stock-based comp of $502K in Q1 2026.
How has Kewaunee Scientific Corporation's stock-based comp changed year-over-year?
Kewaunee Scientific Corporation's stock-based comp increased by 35.7% year-over-year, from $370K to $502K.
What is the long-term trend for Kewaunee Scientific Corporation's stock-based comp?
Over 4 years (2022 to 2026), Kewaunee Scientific Corporation's stock-based comp has grown at a 30.7% compound annual growth rate (CAGR), from $729K to $2.13M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.